{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T21:01:21Z","timestamp":1783371681205,"version":"3.54.6"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,5,20]],"date-time":"2019-05-20T00:00:00Z","timestamp":1558310400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,5,20]],"date-time":"2019-05-20T00:00:00Z","timestamp":1558310400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["01ED1501A"],"award-info":[{"award-number":["01ED1501A"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["01ED1501B"],"award-info":[{"award-number":["01ED1501B"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["01ED1501C"],"award-info":[{"award-number":["01ED1501C"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010146","name":"Alzheimer Forschung Initiative","doi-asserted-by":"publisher","award":["AFI #16004"],"award-info":[{"award-number":["AFI #16004"]}],"id":[{"id":"10.13039\/100010146","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["Open Access Publishing"],"award-info":[{"award-number":["Open Access Publishing"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s40478-019-0726-2","type":"journal-article","created":{"date-parts":[[2019,5,20]],"date-time":"2019-05-20T11:03:22Z","timestamp":1558350202000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Endogenous mouse huntingtin is highly abundant in cranial nerve nuclei, co-aggregates to Abeta plaques and is induced in reactive astrocytes in a transgenic mouse model of Alzheimer\u2019s disease"],"prefix":"10.1186","volume":"7","author":[{"given":"Maike","family":"Hartlage-R\u00fcbsamen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronika","family":"Ratz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Zeitschel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Finzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Machner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janett","family":"K\u00f6ppen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Schulze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Ulrich","family":"Demuth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"von H\u00f6rsten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinna","family":"H\u00f6fling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9959-283X","authenticated-orcid":false,"given":"Steffen","family":"Ro\u00dfner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,20]]},"reference":[{"key":"726_CR1","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1136\/jnnp.38.7.669","volume":"38","author":"SM Aquilonius","year":"1975","unstructured":"Aquilonius SM, Eckern\u00e5s SA, Sundwall A (1975) Regional distribution of choline acetyltransferase in the human brain: changes in Huntington's chorea. J Neurol Neurosurg Psychiatry 38:669\u2013677","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"726_CR2","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/BF02290678","volume":"20","author":"GT Barnes","year":"1994","unstructured":"Barnes GT, Duyao MP, Ambrose CM, McNeil S, Persichetti F, Srinidhi J, Gusella JF, MacDonald ME (1994) Mouse Huntington's disease gene homolog (Hdh). Somat Cell Mol Genet 20:87\u201397","journal-title":"Somat Cell Mol Genet"},{"key":"726_CR3","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1212\/WNL.0b013e3182886a76","volume":"80","author":"EE Benarroch","year":"2013","unstructured":"Benarroch EE (2013) Pedunculopontine nucleus functional organization and clinical implications. Neurology 80:1148\u20131155","journal-title":"Neurology"},{"key":"726_CR4","doi-asserted-by":"publisher","first-page":"5523","DOI":"10.1523\/JNEUROSCI.16-17-05523.1996","volume":"16","author":"PG Bhide","year":"1996","unstructured":"Bhide PG, Day M, Sapp E, Schwarz C, Sheth A, Kim J, Young AB, Penney J, Golden J, Aronin N, DiFiglia M (1996) Expression of normal and mutant huntingtin in the developing brain. J Neurosci 16:5523\u20135535","journal-title":"J Neurosci"},{"key":"726_CR5","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1093\/hmg\/8.9.1647","volume":"8","author":"JM Boutell","year":"1999","unstructured":"Boutell JM, Thomas P, Neal JW, Weston VJ, Duce J, Harper PS, Jones AL (1999) Aberrant interactions of transcriptional repressor proteins with the Huntington's disease gene product, huntingtin. Hum Mol Genet 8:1647\u20131655","journal-title":"Hum Mol Genet"},{"key":"726_CR6","doi-asserted-by":"publisher","first-page":"22480","DOI":"10.1073\/pnas.0911503106","volume":"106","author":"J Bradford","year":"2009","unstructured":"Bradford J, Shin JY, Roberts M, Wang CE, Li XJ, Li S (2009) Expression of mutant huntingtin in mouse brain astrocytes causes age-dependent neurological symptoms. Proc Natl Acad Sci U S A 106:22480\u201322485","journal-title":"Proc Natl Acad Sci U S A"},{"key":"726_CR7","doi-asserted-by":"publisher","first-page":"10653","DOI":"10.1074\/jbc.M109.083287","volume":"285","author":"J Bradford","year":"2010","unstructured":"Bradford J, Shin JY, Roberts M, Wang CE, Sheng G, Li S, Li XJ (2010) Mutant huntingtin in glial cells exacerbates neurological symptoms of Huntington disease mice. J Biol Chem 285:10653\u201310661","journal-title":"J Biol Chem"},{"key":"726_CR8","doi-asserted-by":"publisher","first-page":"3248","DOI":"10.1523\/JNEUROSCI.19-08-03248.1999","volume":"19","author":"RJ Carter","year":"1999","unstructured":"Carter RJ, Lione LA, Humby T, Mangiarini L, Mahal A, Bates GP, Dunnett SB, Morton AJ (1999) Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation. J Neurosci 19:3248\u20133257","journal-title":"J Neurosci"},{"key":"726_CR9","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1038\/nrn1806","volume":"6","author":"E Cattaneo","year":"2005","unstructured":"Cattaneo E, Zuccato C, Tartari M (2005) Normal huntingtin function: an alternative approach to Huntington's disease. Nat Rev Neurosci 6:919\u2013930","journal-title":"Nat Rev Neurosci"},{"key":"726_CR10","first-page":"942","volume":"19","author":"P Chomczynski","year":"1995","unstructured":"Chomczynski P, Mackey K (1995) Short technical reports. Modification of the TRI reagent procedure for isolation of RNA from polysaccharide- and proteoglycan-rich sources. Biotechniques 19:942\u2013945","journal-title":"Biotechniques"},{"key":"726_CR11","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/ncb1901","volume":"11","author":"F Clavaguera","year":"2009","unstructured":"Clavaguera F, Bolmont T, Crowther RA, Abramowski D, Frank S, Probst A, Fraser G, Stalder AK, Beibel M, Staufenbiel M, Jucker M, Goedert M, Tolnay M (2009) Transmission and spreading of tauopathy in transgenic mouse brain. Nat Cell Biol 11:909\u2013913","journal-title":"Nat Cell Biol"},{"key":"726_CR12","doi-asserted-by":"publisher","first-page":"7281","DOI":"10.1523\/JNEUROSCI.0490-10.2010","volume":"30","author":"LK Clinton","year":"2010","unstructured":"Clinton LK, Blurton-Jones M, Myczek K, Trojanowski JQ, LaFerla FM (2010) Synergistic interactions between A\u00df, tau, and \u03b1-synuclein: acceleration of neuropathology and cognitive decline. J Neurosci 30:7281\u20137289","journal-title":"J Neurosci"},{"key":"726_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13195-016-0227-5","volume":"9","author":"CL Dai","year":"2017","unstructured":"Dai CL, Tung YC, Liu F, Gong CX, Iqbal K (2017) Tau passive immunization inhibits not only tau but also A\u03b2 pathology. Alzheimers Res Ther 9:1","journal-title":"Alzheimers Res Ther"},{"key":"726_CR14","doi-asserted-by":"publisher","first-page":"4509","DOI":"10.1523\/JNEUROSCI.5071-13.2014","volume":"34","author":"D Dautan","year":"2014","unstructured":"Dautan D, Huerta-Ocampo I, Witten IB, Deisseroth K, Bolam JP, Gerdjikov T, Mena-Segovia J (2014) A major external source of cholinergic innervation of the striatum and nucleus accumbens originates in the brainstem. J Neurosci 34:4509\u20134518","journal-title":"J Neurosci"},{"key":"726_CR15","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3233\/JHD-140111","volume":"3","author":"MY Davis","year":"2014","unstructured":"Davis MY, Keene CD, Jayadev S, Bird T (2014) The co-occurrence of Alzheimer\u2019s disease and Huntington's disease: a neuropathological study of 15 elderly Huntington's disease subjects. J Huntingtons Dis 3:209\u2013217","journal-title":"J Huntingtons Dis"},{"key":"726_CR16","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1159\/000121389","volume":"5","author":"L Debatin","year":"2008","unstructured":"Debatin L, Streffer J, Geissen M, Matschke J, Aguzzi A, Glatzel M (2008) Association between deposition of beta-amyloid and pathological prion protein in sporadic Creutzfeldt-Jakob disease. Neurodegener Dis 5:347\u2013354","journal-title":"Neurodegener Dis"},{"key":"726_CR17","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/0896-6273(95)90346-1","volume":"14","author":"M DiFiglia","year":"1995","unstructured":"DiFiglia M, Sapp E, Chase K, Schwarz C, Meloni A, Young C, Martin E, Vonsattel JP, Carraway R, Reeves SA, Boyce FM, Aronin N (1995) Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons. Neuron 14:1075\u20131081","journal-title":"Neuron"},{"key":"726_CR18","doi-asserted-by":"publisher","first-page":"333","DOI":"10.3233\/JHD-160200","volume":"5","author":"GX D'Souza","year":"2016","unstructured":"D'Souza GX, Waldvogel HJ (2016) Targeting the cholinergic system to develop a novel therapy for Huntington\u2019s disease. J Huntingtons Dis 5:333\u2013342","journal-title":"J Huntingtons Dis"},{"key":"726_CR19","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1126\/science.7618107","volume":"269","author":"MP Duyao","year":"1995","unstructured":"Duyao MP, Auerbach AB, Ryan A, Persichetti F, Barnes GT, McNeil SM, Ge P, Vonsattel JP, Gusella JF, Joyner AL, MacDonald ME (1995) Inactivation of the mouse Huntington's disease gene homolog Hdh. Science 269:407\u2013410","journal-title":"Science"},{"key":"726_CR20","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/0006-8993(87)90694-9","volume":"411","author":"RJ Ferrante","year":"1987","unstructured":"Ferrante RJ, Beal MF, Kowall NW, Richardson EP Jr, Martin JB (1987) Sparing of acetylcholinesterase-containing striatal neurons in Huntington\u2019s disease. Brain Res 411:162\u2013166","journal-title":"Brain Res"},{"key":"726_CR21","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s004010000271","volume":"101","author":"I Ferrer","year":"2001","unstructured":"Ferrer I, Blanco R, Carmona M, Puig B, Ribera R, Rey MJ, Ribalta T (2001) Prion protein expression in senile plaques in Alzheimer\u2019s disease. Acta Neuropathol 101:49\u201356","journal-title":"Acta Neuropathol"},{"key":"726_CR22","volume-title":"The mouse brain in stereotaxic coordinates","author":"KJB Franklin","year":"1997","unstructured":"Franklin KJB, Paxinos G (1997) The mouse brain in stereotaxic coordinates. Academic Press, San Diego ISBN 0-12-266070-6"},{"key":"726_CR23","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/nn2058","volume":"11","author":"G Gallardo","year":"2008","unstructured":"Gallardo G, Schl\u00fcter OM, S\u00fcdhof TC (2008) A molecular pathway of neurodegeneration linking \u03b1-synuclein to APOE and Abeta peptides. Nat Neurosci 11:301\u2013308","journal-title":"Nat Neurosci"},{"key":"726_CR24","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.cell.2004.06.018","volume":"118","author":"LR Gauthier","year":"2004","unstructured":"Gauthier LR, Charrin BC, Borrell-Pag\u00e8s M, Dompierre JP, Rangone H, Cordeli\u00e8res FP, De Mey J, MacDonald ME, Lessmann V, Humbert S, Saudou F (2004) Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules. Cell 118:127\u2013138","journal-title":"Cell"},{"key":"726_CR25","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1385\/NMM:4:1-2:49","volume":"4","author":"BI Giasson","year":"2003","unstructured":"Giasson BI, Lee VM, Trojanowski JQ (2003) Interactions of Amyloidogenic proteins. NeuroMolecular Med 4:49\u201358","journal-title":"NeuroMolecular Med"},{"key":"726_CR26","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/S0006-291X(84)80190-4","volume":"120","author":"GG Glenner","year":"1984","unstructured":"Glenner GG, Wong CW (1984) Alzheimer\u2019s disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 120:885\u2013890","journal-title":"Biochem Biophys Res Commun"},{"key":"726_CR27","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/ng0896-442","volume":"13","author":"YP Goldberg","year":"1996","unstructured":"Goldberg YP, Nicholson DW, Rasper DM, Kalchman MA, Koide HB, Graham RK, Bromm M, Kazemi-Esfarjani P, Thornberry NA, Vaillancourt JP, Hayden MR (1996) Cleavage of huntingtin by apopain, a proapoptotic cysteine protease, is modulated by the polyglutamine tract. Nat Genet 13:442\u2013449","journal-title":"Nat Genet"},{"key":"726_CR28","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1126\/science.1062097","volume":"293","author":"J G\u00f6tz","year":"2001","unstructured":"G\u00f6tz J, Chen F, van Dorpe J, Nitsch RM (2001) Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils. Science 293:1491\u20131495","journal-title":"Science"},{"key":"726_CR29","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1126\/science.3155875","volume":"227","author":"GA Graveland","year":"1985","unstructured":"Graveland GA, Williams RS, DiFiglia M (1985) Evidence for degenerative and regenerative changes in neostriatal spiny neurons in Huntington\u2019s disease. Science 227:770\u2013773","journal-title":"Science"},{"key":"726_CR30","doi-asserted-by":"publisher","first-page":"6182","DOI":"10.1523\/JNEUROSCI.0857-08.2008","volume":"28","author":"M Gray","year":"2008","unstructured":"Gray M, Shirasaki DI, Cepeda C, Andr\u00e9 VM, Wilburn B, Lu XH, Tao J, Yamazaki I, Li SH, Sun YE, Li XJ, Levine MS, Yang XW (2008) Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice. J Neurosci 28:6182\u20136195","journal-title":"J Neurosci"},{"key":"726_CR31","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1007\/s004010050870","volume":"96","author":"JA Hainfellner","year":"1998","unstructured":"Hainfellner JA, Wanschitz J, Jellinger K, Liberski PP, Gullotta F, Budka H (1998) Coexistence of Alzheimer-type neuropathology in Creutzfeldt-Jakob disease. Acta Neuropathol 96:116\u2013122","journal-title":"Acta Neuropathol"},{"key":"726_CR32","doi-asserted-by":"publisher","first-page":"E3966","DOI":"10.1073\/pnas.1409730111","volume":"111","author":"K Hamada","year":"2014","unstructured":"Hamada K, Terauchi A, Nakamura K, Higo T, Nukina N, Matsumoto N, Hisatsune C, Nakamura T, Mikoshiba K (2014) Aberrant calcium signaling by transglutaminase-mediated posttranslational modification of inositol 1,4,5-trisphosphate receptors. Proc Natl Acad Sci U S A 111:E3966\u2013E3975","journal-title":"Proc Natl Acad Sci U S A"},{"key":"726_CR33","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1111\/j.1750-3639.2000.tb00269.x","volume":"10","author":"RL Hamilton","year":"2000","unstructured":"Hamilton RL (2000) Lewy bodies in Alzheimer\u2019s disease: a neuropathological review of 145 cases using \u03b1-synuclein immunohistochemistry. Brain Pathol 10:378\u2013384","journal-title":"Brain Pathol"},{"key":"726_CR34","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1007\/s00401-011-0806-2","volume":"121","author":"M Hartlage-R\u00fcbsamen","year":"2011","unstructured":"Hartlage-R\u00fcbsamen M, Morawski M, Waniek A, J\u00e4ger C, Zeitschel U, Koch B, Cynis H, Schilling S, Schliebs R, Demuth HU, Ro\u00dfner S (2011) Glutaminyl cyclase contributes to the formation of focal and diffuse pyroglutamate (pGlu)-A\u03b2 deposits in hippocampus via distinct cellular mechanisms. Acta Neuropathol 121:705\u2013719","journal-title":"Acta Neuropathol"},{"key":"726_CR35","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s00401-015-1395-2","volume":"129","author":"M Hartlage-R\u00fcbsamen","year":"2015","unstructured":"Hartlage-R\u00fcbsamen M, Waniek A, Meissner J, Morawski M, Schilling S, J\u00e4ger C, Kleinschmidt M, Cynis H, Kehlen A, Arendt T, Demuth HU, Ro\u00dfner S (2015) Isoglutaminyl cyclase contributes to CCL2-driven neuroinflammation in Alzheimer's disease. Acta Neuropathol 129:565\u2013583","journal-title":"Acta Neuropathol"},{"key":"726_CR36","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1242\/jcs.115.5.941","volume":"115","author":"G Hoffner","year":"2002","unstructured":"Hoffner G, Kahlem P, Djian P (2002) Perinuclear localization of huntingtin as a consequence of its binding to microtubules through an interaction with beta-tubulin: relevance to Huntington\u2019s disease. J Cell Sci 115:941\u2013948","journal-title":"J Cell Sci"},{"key":"726_CR37","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1093\/hmg\/2.12.2069","volume":"2","author":"AT Hoogeveen","year":"1993","unstructured":"Hoogeveen AT, Willemsen R, Meyer N, de Rooij KE, Roos RA, van Ommen GJ, Galjaard H (1993) Characterization and localization of the Huntington disease gene product. Hum Mol Genet 2:2069\u20132073","journal-title":"Hum Mol Genet"},{"key":"726_CR38","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1110\/ps.041266605","volume":"14","author":"P Hortschansky","year":"2005","unstructured":"Hortschansky P, Schroeckh V, Christopeit T, Zandomeneghi G, F\u00e4ndrich M (2005) The aggregation kinetics of Alzheimer\u2019s beta-amyloid peptide is controlled by stochastic nucleation. Protein Sci 14:1753\u20131759","journal-title":"Protein Sci"},{"key":"726_CR39","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1126\/science.274.5284.99","volume":"274","author":"K Hsiao","year":"1996","unstructured":"Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S, Yang F, Cole G (1996) Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 274:99\u2013102","journal-title":"Science"},{"key":"726_CR40","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1007\/s007020050095","volume":"105","author":"KA Jellinger","year":"1998","unstructured":"Jellinger KA (1998) Alzheimer-type lesions in Huntington\u2019s disease. J Neural Transm 105:787\u2013799","journal-title":"J Neural Transm"},{"key":"726_CR41","doi-asserted-by":"publisher","first-page":"3606","DOI":"10.1523\/JNEUROSCI.20-10-03606.2000","volume":"20","author":"MD Kane","year":"2000","unstructured":"Kane MD, Lipinski WJ, Callahan MJ, Bian F, Durham RA, Schwarz RD, Roher AE, Walker LC (2000) Evidence for seeding of beta-amyloid by intracerebral infusion of Alzheimer brain extracts in beta-amyloid precursor protein-transgenic mice. J Neurosci 20:3606\u20133611","journal-title":"J Neurosci"},{"key":"726_CR42","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1523\/JNEUROSCI.21-02-00372.2001","volume":"21","author":"T Kawarabayashi","year":"2001","unstructured":"Kawarabayashi T, Younkin LH, Saido TC, Shoji M, Ashe KH, Younkin SG (2001) Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer\u2019s disease. J Neurosci 21:372\u2013381","journal-title":"J Neurosci"},{"key":"726_CR43","doi-asserted-by":"publisher","first-page":"7466","DOI":"10.1074\/jbc.M103946200","volume":"277","author":"KB Kegel","year":"2002","unstructured":"Kegel KB, Meloni AR, Yi Y, Kim YJ, Doyle E, Cuiffo BG, Sapp E, Wang Y, Qin ZH, Chen JD, Nevins JR, Aronin N, DiFiglia M (2002) Huntingtin is present in the nucleus, interacts with the transcriptional corepressor C-terminal binding protein, and represses transcription. J Biol Chem 277:7466\u20137476","journal-title":"J Biol Chem"},{"key":"726_CR44","doi-asserted-by":"publisher","first-page":"12784","DOI":"10.1073\/pnas.221451398","volume":"98","author":"YJ Kim","year":"2001","unstructured":"Kim YJ, Yi Y, Sapp E, Wang Y, Cuiffo B, Kegel KB, Qin ZH, Aronin N, DiFiglia M (2001) Caspase 3-cleaved N-terminal fragments of wild-type and mutant huntingtin are present in normal and Huntington's disease brains, associate with membranes, and undergo calpain-dependent proteolysis. Proc Natl Acad Sci U S A 98:12784\u201312789","journal-title":"Proc Natl Acad Sci U S A"},{"key":"726_CR45","doi-asserted-by":"publisher","first-page":"8808","DOI":"10.1074\/jbc.M109.075028","volume":"285","author":"C Landles","year":"2010","unstructured":"Landles C, Sathasivam K, Weiss A, Woodman B, Moffitt H, Finkbeiner S, Sun B, Gafni J, Ellerby LM, Trottier Y, Richards WG, Osmand A, Paganetti P, Bates GP (2010) Proteolysis of mutant huntingtin produces an exon 1 fragment that accumulates as an aggregated protein in neuronal nuclei in Huntington disease. J Biol Chem 285:8808\u20138823","journal-title":"J Biol Chem"},{"key":"726_CR46","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s00401-007-0336-0","volume":"115","author":"T Lashley","year":"2008","unstructured":"Lashley T, Holton JL, Gray E, Kirkham K, O'Sullivan SS, Hilbig A, Wood NW, Lees AJ, Revesz T (2008) Cortical alpha-synuclein load is associated with amyloid-beta plaque burden in a subset of Parkinson\u2019s disease patients. Acta Neuropathol 115:417\u2013425","journal-title":"Acta Neuropathol"},{"key":"726_CR47","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1212\/WNL.0b013e318249f683","volume":"78","author":"JM Lee","year":"2012","unstructured":"Lee JM, Ramos EM, Lee JH, Gillis T, Mysore JS, Hayden MR, Warby SC, Morrison P, Nance M, Ross CA, Margolis RL, Squitieri F, Orobello S, Di Donato S, Gomez-Tortosa E, Ayuso C, Suchowersky O, Trent RJ, McCusker E, Novelletto A, Frontali M, Jones R, Ashizawa T, Frank S, Saint-Hilaire MH, Hersch SM, Rosas HD, Lucente D, Harrison MB, Zanko A, Abramson RK, Marder K, Sequeiros J, Paulsen JS, PREDICT-HD study of the Huntington Study Group (HSG), Landwehrmeyer GB; REGISTRY study of the European Huntington\u2019s Disease Network, Myers RH; HD-MAPS Study Group, MacDonald ME, Gusella JF; COHORT study of the HSG (2012) CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion. Neurology 78:690\u2013695","journal-title":"Neurology"},{"key":"726_CR48","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1001\/archneur.1985.04060010063017","volume":"42","author":"NA Leopold","year":"1985","unstructured":"Leopold NA, Kagel MC (1985) Dysphagia in Huntington\u2019s disease. Arch Neurol 42:57\u201360","journal-title":"Arch Neurol"},{"key":"726_CR49","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/78054","volume":"25","author":"H Li","year":"2000","unstructured":"Li H, Li SH, Johnston H, Shelbourne PF, Li XJ (2000) Amino-terminal fragments of mutant huntingtin show selective accumulation in striatal neurons and synaptic toxicity. Nat Genet 25:385\u2013389","journal-title":"Nat Genet"},{"key":"726_CR50","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1093\/hmg\/10.2.137","volume":"10","author":"CH Lin","year":"2001","unstructured":"Lin CH, Tallaksen-Greene S, Chien WM, Cearley JA, Jackson WS, Crouse AB, Ren S, Li XJ, Albin RL, Detloff PJ (2001) Neurological abnormalities in a knock-in mouse model of Huntington's disease. Hum Mol Genet 10:137\u2013144","journal-title":"Hum Mol Genet"},{"key":"726_CR51","doi-asserted-by":"publisher","first-page":"20051","DOI":"10.1073\/pnas.0908005106","volume":"106","author":"KC Luk","year":"2009","unstructured":"Luk KC, Song C, O'Brien P, Stieber A, Branch JR, Brunden KR, Trojanowski JQ, Lee VM (2009) Exogenous alpha-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells. Proc Natl Acad Sci U S A 106:20051\u201320056","journal-title":"Proc Natl Acad Sci U S A"},{"key":"726_CR52","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1007\/s11064-006-9140-9","volume":"31","author":"PK Mandal","year":"2006","unstructured":"Mandal PK, Pettegrew JW, Masliah E, Hamilton RL, Mandal R (2006) Interaction between Abeta peptide and \u03b1-synuclein: molecular mechanisms in overlapping pathology of Alzheimer\u2019s and Parkinson\u2019s in dementia with Lewy bodies. Neurochem Res 31:1153\u20131162","journal-title":"Neurochem Res"},{"key":"726_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S1092852918001037","volume":"10","author":"Y Manor","year":"2018","unstructured":"Manor Y, Oestreicher-Kedem Y, Gad A, Zitser J, Faust-Socher A, Shpunt D, Naor S, Inbar N, Kestenbaum M, Giladi N, Gurevich T (2018) Dysphagia characteristics in Huntington's disease patients: insights from the fiberoptic endoscopic evaluation of swallowing and the swallowing disturbances questionnaire. CNS Spectr 10:1\u20136","journal-title":"CNS Spectr"},{"key":"726_CR54","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1212\/WNL.54.2.452","volume":"54","author":"K Marder","year":"2000","unstructured":"Marder K, Zhao H, Myers RH, Cudkowicz M, Kayson E, Kieburtz K, Orme C, Paulsen J, Penney JB Jr, Siemers E, Shoulson I (2000) Rate of functional decline in Huntington\u2019s disease. Huntington Study Group. Neurology 54:452\u2013458","journal-title":"Neurology"},{"key":"726_CR55","doi-asserted-by":"publisher","first-page":"12245","DOI":"10.1073\/pnas.211412398","volume":"98","author":"E Masliah","year":"2001","unstructured":"Masliah E, Rockenstein E, Veinbergs I, Sagara Y, Mallory M, Hashimoto M, Mucke L (2001) \u03b2-Amyloid peptides enhance \u03b1-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease. Proc Natl Acad Sci U S A 98:12245\u201312250","journal-title":"Proc Natl Acad Sci U S A"},{"key":"726_CR56","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1471-2091-14-34","volume":"14","author":"L Massai","year":"2013","unstructured":"Massai L, Petricca L, Magnoni L, Rovetini L, Haider S, Andre R, Tabrizi SJ, S\u00fcssmuth SD, Landwehrmeyer BG, Caricasole A, Pollio G, Bernocco S (2013) Development of an ELISA assay for the quantification of soluble huntingtin in human blood cells. BMC Biochem 14:34","journal-title":"BMC Biochem"},{"key":"726_CR57","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1523\/JNEUROSCI.21-06-01830.2001","volume":"2","author":"LM Mende-Mueller","year":"2001","unstructured":"Mende-Mueller LM, Toneff T, Hwang SR, Chesselet MF, Hook VY (2001) Tissue-specific proteolysis of huntingtin (htt) in human brain: evidence of enhanced levels of N- and C-terminal htt fragments in Huntington\u2019s disease striatum. J Neurosci 2:1830\u20131837","journal-title":"J Neurosci"},{"key":"726_CR58","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1016\/j.jmb.2011.12.011","volume":"415","author":"R Mishra","year":"2012","unstructured":"Mishra R, Jayaraman M, Roland BP, Landrum E, Fullam T, Kodali R, Thakur AK, Arduini I, Wetzel R (2012) Inhibiting the nucleation of amyloid structure in a huntingtin fragment by targeting \u03b1-helix-rich oligomeric intermediates. J Mol Biol 415:900\u2013917","journal-title":"J Mol Biol"},{"key":"726_CR59","doi-asserted-by":"publisher","first-page":"4528","DOI":"10.1523\/JNEUROSCI.5924-09.2010","volume":"30","author":"R Morales","year":"2010","unstructured":"Morales R, Estrada LD, Diaz-Espinoza R, Morales-Scheihing D, Jara MC, Castilla J, Soto C (2010) Molecular cross talk between misfolded proteins in animal models of Alzheimer's and prion diseases. J Neurosci 30:4528\u20134535","journal-title":"J Neurosci"},{"key":"726_CR60","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/nature13186","volume":"508","author":"SW Oh","year":"2014","unstructured":"Oh SW, Harris JA, Ng L, Winslow B, Cain N, Mihalas S, Wang Q, Lau C, Kuan L, Henry AM, Mortrud MT, Ouellette B, Nguyen TN, Sorensen SA, Slaughterbeck CR, Wakeman W, Li Y, Feng D, Ho A, Nicholas E, Hirokawa KE, Bohn P, Joines KM, Peng H, Hawrylycz MJ, Phillips JW, Hohmann JG, Wohnoutka P, Gerfen CR, Koch C, Bernard A, Dang C, Jones AR, Zeng H (2014) A mesoscale connectome of the mouse brain. Nature 508:207\u2013214","journal-title":"Nature"},{"key":"726_CR61","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1096\/fj.03-0338rev","volume":"18","author":"A Recchia","year":"2004","unstructured":"Recchia A, Debetto P, Negro A, Guidolin D, Skaper SD, Giusti P (2004) Alpha-synuclein and Parkinson\u2019s disease. FASEB J 18:617\u2013626","journal-title":"FASEB J"},{"key":"726_CR62","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1002\/mds.23243","volume":"25","author":"R Reilmann","year":"2010","unstructured":"Reilmann R, Bohlen S, Klopstock T, Bender A, Weindl A, Saemann P, Auer DP, Ringelstein EB, Lange HW (2010) Tongue force analysis assesses motor phenotype in premanifest and symptomatic Huntington\u2019s disease. Mov Disord 25:2195\u20132202","journal-title":"Mov Disord"},{"key":"726_CR63","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/bpa.12115","volume":"24","author":"U R\u00fcb","year":"2014","unstructured":"R\u00fcb U, Hentschel M, Stratmann K, Brunt E, Heinsen H, Seidel K, Bouzrou M, Auburger G, Paulson H, Vonsattel JP, Lange H, Korf HW, den Dunnen W (2014) Huntington\u2019s disease (HD): degeneration of select nuclei, widespread occurrence of neuronal nuclear and axonal inclusions in the brainstem. Brain Pathol 24:247\u2013260","journal-title":"Brain Pathol"},{"key":"726_CR64","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1002\/ana.410420411","volume":"42","author":"E Sapp","year":"1997","unstructured":"Sapp E, Schwarz C, Chase K, Bhide PG, Young AB, Penney J, Vonsattel JP, Aronin N, DiFiglia M (1997) Huntingtin localization in brains of normal and Huntington\u2019s disease patients. Ann Neurol 42:604\u2013612","journal-title":"Ann Neurol"},{"key":"726_CR65","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.neuron.2016.02.003","volume":"89","author":"F Saudou","year":"2016","unstructured":"Saudou F, Humbert S (2016) The biology of huntingtin. Neuron 89:910\u2013926","journal-title":"Neuron"},{"key":"726_CR66","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1097\/nen.0b013e318040b2c8","volume":"66","author":"G Schilling","year":"2007","unstructured":"Schilling G, Klevytska A, Tebbenkamp AT, Juenemann K, Cooper J, Gonzales V, Slunt H, Poirer M, Ross CA, Borchelt DR (2007) Characterization of huntingtin pathologic fragments in human Huntington disease, transgenic mice, and cell models. J Neuropathol Exp Neurol 66:313\u2013320","journal-title":"J Neuropathol Exp Neurol"},{"key":"726_CR67","doi-asserted-by":"publisher","first-page":"7072","DOI":"10.1021\/bi900818a","volume":"48","author":"D Schlenzig","year":"2009","unstructured":"Schlenzig D, Manhart S, Cinar Y, Kleinschmidt M, Hause G, Willbold D, Funke SA, Schilling S, Demuth HU (2009) Pyroglutamate formation influences solubility and amyloidogenicity of amyloid peptides. Biochemistry 48:7072\u20137078","journal-title":"Biochemistry"},{"key":"726_CR68","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1111\/j.1471-4159.2012.07707.x","volume":"121","author":"D Schlenzig","year":"2012","unstructured":"Schlenzig D, R\u00f6nicke R, Cynis H, Ludwig HH, Scheel E, Reymann K, Saido T, Hause G, Schilling S, Demuth HU (2012) N-terminal pyroglutamate formation of A\u03b238 and A\u03b240 enforces oligomer formation and potency to disrupt hippocampal long-term potentiation. J Neurochem 121:774\u2013784","journal-title":"J Neurochem"},{"key":"726_CR69","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1093\/hmg\/ddp524","volume":"19","author":"IS Seong","year":"2010","unstructured":"Seong IS, Woda JM, Song JJ, Lloret A, Abeyrathne PD, Woo CJ, Gregory G, Lee JM, Wheeler VC, Walz T, Kingston RE, Gusella JF, Conlon RA, MacDonald ME (2010) Huntingtin facilitates polycomb repressive complex 2. Hum Mol Genet 19:573\u2013583","journal-title":"Hum Mol Genet"},{"key":"726_CR70","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/0896-6273(95)90345-3","volume":"14","author":"AH Sharp","year":"1995","unstructured":"Sharp AH, Loev SJ, Schilling G, Li SH, Li XJ, Bao J, Wagster MV, Kotzuk JA, Steiner JP, Lo A, Hedreen J, Sisodia S, Snyder SH, Dawson TM, Ryugo DK, Ross CA (1995) Widespread expression of Huntington's disease gene (IT15) protein product. Neuron 14:1065\u20131074","journal-title":"Neuron"},{"key":"726_CR71","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1083\/jcb.200508072","volume":"171","author":"JY Shin","year":"2005","unstructured":"Shin JY, Fang ZH, Yu ZX, Wang CE, Li SH, Li XJ (2005) Expression of mutant huntingtin in glial cells contributes to neuronal excitotoxicity. J Cell Biol 171:1001\u20131012","journal-title":"J Cell Biol"},{"key":"726_CR72","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1006\/exnr.1998.6778","volume":"150","author":"SK Singhrao","year":"1998","unstructured":"Singhrao SK, Thomas P, Wood JD, MacMillan JC, Neal JW, Harper PS, Jones AL (1998) Huntingtin protein colocalizes with lesions of neurodegenerative diseases: an investigation in Huntington's, Alzheimer's, and Pick's diseases. Exp Neurol 150:213\u2013222","journal-title":"Exp Neurol"},{"key":"726_CR73","doi-asserted-by":"publisher","first-page":"3119","DOI":"10.1093\/hmg\/ddl252","volume":"15","author":"R Smith","year":"2006","unstructured":"Smith R, Chung H, Rundquist S, Maat-Schieman ML, Colgan L, Englund E, Liu YJ, Roos RA, Faull RL, Brundin P, Li JY (2006) Cholinergic neuronal defect without cell loss in Huntington's disease. Hum Mol Genet 15:3119\u20133131","journal-title":"Hum Mol Genet"},{"key":"726_CR74","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1016\/S0006-3495(94)80591-0","volume":"67","author":"SW Snyder","year":"1994","unstructured":"Snyder SW, Ladror US, Wade WS, Wang GT, Barrett LW, Matayoshi ED, Huffaker HJ, Krafft GA, Holzman TF (1994) Amyloid-beta aggregation: selective inhibition of aggregation in mixtures of amyloid with different chain lengths. Biophys J 67:1216\u20131228","journal-title":"Biophys J"},{"key":"726_CR75","doi-asserted-by":"publisher","first-page":"12166","DOI":"10.1038\/srep12166","volume":"5","author":"AL Southwell","year":"2015","unstructured":"Southwell AL, Smith SE, Davis TR, Caron NS, Villanueva EB, Xie Y, Collins JA, Ye ML, Sturrock A, Leavitt BR, Schrum AG, Hayden MR (2015) Ultrasensitive measurement of huntingtin protein in cerebrospinal fluid demonstrates increase with Huntington disease stage and decrease following brain huntingtin suppression. Sci Rep 5:12166","journal-title":"Sci Rep"},{"key":"726_CR76","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s00401-017-1786-7","volume":"135","author":"I St-Amour","year":"2018","unstructured":"St-Amour I, Turgeon A, Goupil C, Planel E, H\u00e9bert SS (2018) Co-occurrence of mixed proteinopathies in late-stage Huntington\u2019s disease. Acta Neuropathol 135:249\u2013265","journal-title":"Acta Neuropathol"},{"key":"726_CR77","doi-asserted-by":"publisher","first-page":"6763","DOI":"10.1073\/pnas.100110097","volume":"97","author":"JS Steffan","year":"2000","unstructured":"Steffan JS, Kazantsev A, Spasic-Boskovic O, Greenwald M, Zhu YZ, Gohler H, Wanker EE, Bates GP, Housman DE, Thompson LM (2000) The Huntington\u2019s disease protein interacts with p53 and CREB-binding protein and represses transcription. Proc Natl Acad Sci U S A 97:6763\u20136768","journal-title":"Proc Natl Acad Sci U S A"},{"key":"726_CR78","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.brainres.2014.11.063","volume":"1597","author":"L Stiles","year":"2015","unstructured":"Stiles L, Smith PF (2015) The vestibular-basal ganglia connection: balancing motor control. Brain Res 1597:180\u2013188","journal-title":"Brain Res"},{"key":"726_CR79","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1212\/WNL.0b013e3181f25b35","volume":"75","author":"EW Tsang","year":"2010","unstructured":"Tsang EW, Hamani C, Moro E, Mazzella F, Poon YY, Lozano AM, Chen R (2010) Involvement of the human pedunculopontine nucleus region in voluntary movements. Neurology 75:950\u2013959","journal-title":"Neurology"},{"key":"726_CR80","doi-asserted-by":"publisher","first-page":"e3135","DOI":"10.1371\/journal.pone.0003135","volume":"3","author":"IF Tsigelny","year":"2008","unstructured":"Tsigelny IF, Crews L, Desplats P, Shaked GM, Sharikov Y, Mizuno H, Spencer B, Rockenstein E, Trejo M, Platoshyn O, Yuan JX, Masliah E (2008) Mechanisms of hybrid oligomer formation in the pathogenesis of combined Alzheimer\u2019s and Parkinson\u2019s diseases. PLoS One 3:e3135","journal-title":"PLoS One"},{"key":"726_CR81","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1476-5926-9-8","volume":"9","author":"E Ueberham","year":"2010","unstructured":"Ueberham E, B\u00f6ttger J, Ueberham U, Grosche J, Gebhardt R (2010) Response of sinusoidal mouse liver cells to choline-deficient ethionine-supplemented diet. Comp Hepatol 9:8","journal-title":"Comp Hepatol"},{"key":"726_CR82","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1006\/exnr.1998.6832","volume":"152","author":"J Velier","year":"1998","unstructured":"Velier J, Kim M, Schwarz C, Kim TW, Sapp E, Chase K, Aronin N, DiFiglia M (1998) Wild-type and mutant huntingtins function in vesicle trafficking in the secretory and endocytic pathways. Exp Neurol 152:34\u201340","journal-title":"Exp Neurol"},{"key":"726_CR83","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s00401-007-0306-6","volume":"115","author":"JP Vonsattel","year":"2008","unstructured":"Vonsattel JP (2008) Huntington disease models and human neuropathology: similarities and differences. Acta Neuropathol 115:55\u201369","journal-title":"Acta Neuropathol"},{"key":"726_CR84","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1097\/00005072-199805000-00001","volume":"57","author":"JP Vonsattel","year":"1998","unstructured":"Vonsattel JP, DiFiglia M (1998) Huntington disease. J Neuropathol Exp Neurol 57:369\u2013384","journal-title":"J Neuropathol Exp Neurol"},{"key":"726_CR85","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","volume":"44","author":"JP Vonsattel","year":"1985","unstructured":"Vonsattel JP, Myers RH, Stevens TJ, Ferrante RJ, Bird ED, Richardson EP Jr (1985) Neuropathological classification of Huntington\u2019s disease. J Neuropathol Exp Neurol 44:559\u2013577","journal-title":"J Neuropathol Exp Neurol"},{"key":"726_CR86","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/S0140-6736(07)60111-1","volume":"369","author":"FO Walker","year":"2007","unstructured":"Walker FO (2007) Huntington\u2019s disease. Lancet 369:218\u2013228","journal-title":"Lancet"},{"key":"726_CR87","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1111\/j.1750-3639.1997.tb00897.x","volume":"7","author":"CL Wellington","year":"1997","unstructured":"Wellington CL, Brinkman RR, O'Kusky JR, Hayden MR (1997) Toward understanding the molecular pathology of Huntington's disease. Brain Pathol 7:979\u20131002","journal-title":"Brain Pathol"},{"key":"726_CR88","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1093\/hmg\/5.4.481","volume":"5","author":"JD Wood","year":"1996","unstructured":"Wood JD, MacMillan JC, Harper PS, Lowenstein PR, Jones AL (1996) Partial characterisation of murine huntingtin and apparent variations in the subcellular localisation of huntingtin in human, mouse and rat brain. Hum Mol Genet 5:481\u2013487","journal-title":"Hum Mol Genet"},{"key":"726_CR89","first-page":"487","volume":"28","author":"TE Wood","year":"2019","unstructured":"Wood TE, Barry J, Yang Z, Cepeda C, Levine MS, Gray M (2019) Mutant huntingtin reduction in astrocytes slows disease progression in the BACHD conditional Huntington's disease mouse model. Hum Mol Genet 28:487\u2013500","journal-title":"Hum Mol Genet"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-019-0726-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40478-019-0726-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-019-0726-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,18]],"date-time":"2022-09-18T08:39:09Z","timestamp":1663490349000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-019-0726-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,20]]},"references-count":89,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["726"],"URL":"https:\/\/doi.org\/10.1186\/s40478-019-0726-2","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,20]]},"assertion":[{"value":"16 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All applicable international, national, and\/or institutional guidelines for the care and use of animals were followed. All experiments carried out were in agreement with European regulations on the protection of animals used for scientific purposes (Directive 2010\/63\/EU), and they were also approved by the Ethical Committee for Animal Research of Landesdirektion Sachsen, license numbers T11\/16, T14\/16 and T28\/16.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All the authors have approved publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"79"}}